Works matching AU Nishio, Shin

Results: 172
    1
    2
    3
    4
    5
    6

    Changes in the Clinicopathological Demographics of Vulvar Cancer in Japan: Increasing Oldest-Old, Stage Shifting, and Decreasing Cohort-Level Survival †.

    Published in:
    Journal of Clinical Medicine, 2019, v. 8, n. 12, p. 2081, doi. 10.3390/jcm8122081
    By:
    • Nishio, Shin;
    • Matsuo, Koji;
    • Shibata, Takeo;
    • Yamaguchi, Satoshi;
    • Kanao, Hiroyuki;
    • Takehara, Kazuhiro;
    • Kado, Nobuhiro;
    • Tozawa, Akiko;
    • Tokunaga, Hideki;
    • Matsunaga, Tatsuya;
    • Kato, Hisamori;
    • Horie, Koji;
    • Kikuchi, Akira;
    • Enomoto, Takayuki;
    • Mikami, Mikio
    Publication type:
    Article
    7
    8

    Pembrolizumab plus chemotherapy in Japanese patients with persistent, recurrent or metastatic cervical cancer: Results from KEYNOTE‐826.

    Published in:
    Cancer Science, 2022, v. 113, n. 11, p. 3877, doi. 10.1111/cas.15479
    By:
    • Nishio, Shin;
    • Yonemori, Kan;
    • Usami, Tomoka;
    • Minobe, Shinichiro;
    • Yunokawa, Mayu;
    • Iwata, Takashi;
    • Okamoto, Aikou;
    • Aoki, Yoichi;
    • Itamochi, Hiroaki;
    • Takekuma, Munetaka;
    • Harano, Kenichi;
    • Yamamoto, Keiko;
    • Maruko, Takeshi;
    • Ugai, Hiroyuki;
    • Tekin, Cumhur;
    • Colombo, Nicoletta;
    • Fujiwara, Keiichi;
    • Hasegawa, Kosei;
    • Ushijima, Kimio
    Publication type:
    Article
    9

    Adjuvant Chemotherapy for Endometrial Cancer (ACE) trial: A randomized phase II study for advanced endometrial carcinoma.

    Published in:
    Cancer Science, 2022, v. 113, n. 5, p. 1693, doi. 10.1111/cas.15310
    By:
    • Egawa‐Takata, Tomomi;
    • Ueda, Yutaka;
    • Ito, Kimihiko;
    • Hori, Kensuke;
    • Tadahiro, Shoji;
    • Nagasawa, Takayuki;
    • Nishio, Shin;
    • Ushijima, Kimio;
    • Koji, Nishino;
    • Enomoto, Takayuki;
    • Kikuchi, Akira;
    • Honma, Shigeru;
    • Oishi, Tetsuro;
    • Shimada, Muneaki;
    • Takei, Yuji;
    • Fujiwara, Hiroyuki;
    • Tanabe, Hiroshi;
    • Okamoto, Aikou;
    • Nishio, Yukihiro;
    • Yamada, Tomomi
    Publication type:
    Article
    10
    11
    12

    Phase 1 study of veliparib with carboplatin and weekly paclitaxel in Japanese patients with newly diagnosed ovarian cancer.

    Published in:
    Cancer Science, 2017, v. 108, n. 11, p. 2213, doi. 10.1111/cas.13381
    By:
    • Nishio, Shin;
    • Takekuma, Munetaka;
    • Takeuchi, Satoshi;
    • Kawano, Kouichirou;
    • Tsuda, Naotake;
    • Tasaki, Kazuto;
    • Takahashi, Nobutaka;
    • Abe, Masakazu;
    • Tanaka, Aki;
    • Nagasawa, Takayuki;
    • Shoji, Tadahiro;
    • Xiong, Hao;
    • Nuthalapati, Silpa;
    • Leahy, Terri;
    • Hashiba, Hideyuki;
    • Kiriyama, Tsukasa;
    • Komarnitsky, Philip;
    • Hirashima, Yasuyuki;
    • Ushijima, Kimio
    Publication type:
    Article
    13

    Y-box binding protein 1/cyclin A1 axis specifically promotes cell cycle progression at G<sub>2</sub>/M phase in ovarian cancer.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-72174-9
    By:
    • Murakami, Yuichi;
    • Katsuchi, Daisuke;
    • Matsumoto, Taichi;
    • Kanazawa, Kuon;
    • Shibata, Tomohiro;
    • Kawahara, Akihiko;
    • Akiba, Jun;
    • Yanaihara, Nozomu;
    • Okamoto, Aikou;
    • Itamochi, Hiroaki;
    • Sugiyama, Toru;
    • Terada, Atsumu;
    • Nishio, Shin;
    • Tsuda, Naotake;
    • Kato, Kiyoko;
    • Ono, Mayumi;
    • Kuwano, Michihiko
    Publication type:
    Article
    14

    The prevalence and clinical features of MYO7A-related hearing loss including DFNA11, DFNB2 and USH1B.

    Published in:
    Scientific Reports, 2024, v. 14, n. 1, p. 1, doi. 10.1038/s41598-024-57415-1
    By:
    • Watanabe, Kizuki;
    • Nishio, Shin-ya;
    • Usami, Shin-ichi;
    • Kumai, Takumi;
    • Katada, Akihiro;
    • Ogasawara, Noriko;
    • Shintani, Tomoko;
    • Morita, Shin-ya;
    • Takeichi, Norito;
    • Goto, Shin-ichi;
    • Nanba, Atsushi;
    • Sasaki, Akira;
    • Kobayashi, Yumiko;
    • Honkura, Yohei;
    • Adachi, Mika;
    • Takai, Shunsuke;
    • Oda, Kiyoshi;
    • Sato, Teruyuki;
    • Yamada, Takechiyo;
    • Shiina, Kazuhiro
    Publication type:
    Article
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24

    What is an appropriate second-line regimen for recurrent endometrial cancer? Ancillary analysis of the SGSG012/GOTIC004/Intergroup study.

    Published in:
    Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 2, p. 335, doi. 10.1007/s00280-015-2793-9
    By:
    • Nagao, Shoji;
    • Nishio, Shin;
    • Okada, Satoshi;
    • Otsuki, Takeo;
    • Fujiwara, Kiyoshi;
    • Tanabe, Hiroshi;
    • Takano, Masashi;
    • Hasumi, Yoko;
    • Takei, Yuji;
    • Hasegawa, Tetsuya;
    • Matsumoto, Takashi;
    • Fujiwara, Keiichi;
    • Takekuma, Munetaka;
    • Nakamura, Kazuto;
    • Shimada, Muneaki;
    • Suzuki, Mitsuaki;
    • Kigawa, Junzo
    Publication type:
    Article
    25
    26
    27
    28
    29
    30
    31
    32
    33
    34
    35
    36

    A retrospective assessment of the safety and efficacy of laparoscopic radical hysterectomy in Japan during the early years following its introduction: a Japanese Gynecologic Oncology Group study (JGOG1081S).

    Published in:
    International Journal of Clinical Oncology, 2021, v. 26, n. 2, p. 417, doi. 10.1007/s10147-020-01799-3
    By:
    • Kobayashi, Eiji;
    • Kanao, Hiroyuki;
    • Takekuma, Munetaka;
    • Nishio, Shin;
    • Kojima-Chiba, Atsumi;
    • Tozawa, Akiko;
    • Yamaguchi, Satoshi;
    • Takeshima, Nobuhiro;
    • Nakatani, Eiji;
    • Mikami, Mikio
    Publication type:
    Article
    37

    A phase II randomized controlled study of pegylated liposomal doxorubicin and carboplatin vs. gemcitabine and carboplatin for platinum-sensitive recurrent ovarian cancer (GOTIC003/intergroup study).

    Published in:
    International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1284, doi. 10.1007/s10147-019-01471-5
    By:
    • Fujiwara, Hiroyuki;
    • Ushijima, Kimio;
    • Nagao, Shoji;
    • Takei, Yuji;
    • Shimada, Muneaki;
    • Takano, Masashi;
    • Yoshino, Kiyoshi;
    • Kawano, Yoshiaki;
    • Hirashima, Yasuyuki;
    • Nagase, Satoru;
    • Nishio, Shin;
    • Nishikawa, Tadaaki;
    • Ito, Kimihiko;
    • Shoji, Tadahiro;
    • Kimura, Eizo;
    • Takano, Tadao;
    • Sugiyama, Toru;
    • Kigawa, Junzo;
    • Fujiwara, Keiichi;
    • Suzuki, Mitsuaki
    Publication type:
    Article
    38
    39
    40
    41

    WFS1 mutation screening in a large series of Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis.

    Published in:
    PLoS ONE, 2018, v. 13, n. 3, p. 1, doi. 10.1371/journal.pone.0193359
    By:
    • Kobayashi, Masafumi;
    • Miyagawa, Maiko;
    • Nishio, Shin-ya;
    • Moteki, Hideaki;
    • Fujikawa, Taro;
    • Ohyama, Kenji;
    • Sakaguchi, Hirofumi;
    • Miyanohara, Ikuyo;
    • Sugaya, Akiko;
    • Naito, Yasushi;
    • Morita, Shin-ya;
    • Kanda, Yukihiko;
    • Takahashi, Masahiro;
    • Ishikawa, Kotaro;
    • Nagano, Yuki;
    • Tono, Tetsuya;
    • Oshikawa, Chie;
    • Kihara, Chiharu;
    • Takahashi, Haruo;
    • Noguchi, Yoshihiro
    Publication type:
    Article
    42

    POU4F3 mutation screening in Japanese hearing loss patients: Massively parallel DNA sequencing-based analysis identified novel variants associated with autosomal dominant hearing loss.

    Published in:
    PLoS ONE, 2017, v. 12, n. 5, p. 1, doi. 10.1371/journal.pone.0177636
    By:
    • Kitano, Tomohiro;
    • Miyagawa, Maiko;
    • Nishio, Shin-ya;
    • Moteki, Hideaki;
    • Oda, Kiyoshi;
    • Ohyama, Kenji;
    • Miyazaki, Hiromitsu;
    • Hidaka, Hiroshi;
    • Nakamura, Ken-ichi;
    • Murata, Takaaki;
    • Matsuoka, Rina;
    • Ohta, Yoko;
    • Nishiyama, Nobuhiro;
    • Kumakawa, Kozo;
    • Furutate, Sakiko;
    • Iwasaki, Satoshi;
    • Yamada, Takechiyo;
    • Ohta, Yumi;
    • Uehara, Natsumi;
    • Noguchi, Yoshihiro
    Publication type:
    Article
    43
    44
    45

    Usefulness of third-line chemotherapy for women with recurrent ovarian, fallopian tube, and primary peritoneal cancer who receive platinum/taxane regimens as first-line therapy.

    Published in:
    Journal of Cancer Research & Clinical Oncology, 2009, v. 135, n. 4, p. 551, doi. 10.1007/s00432-008-0488-x
    By:
    • Nishio, Shin;
    • Katsumata, Noriyuki;
    • Matsumoto, Koji;
    • Tanabe, Hiroshi;
    • Yonemori, Kan;
    • Kouno, Tsutomu;
    • Shimizu, Chikako;
    • Ando, Masashi;
    • Kamura, Toshiharu;
    • Kasamatsu, Takahiro;
    • Fujiwara, Yasuhiro
    Publication type:
    Article
    46
    47

    Prevalence and clinical features of hearing loss caused by EYA4 variants.

    Published in:
    Scientific Reports, 2020, v. 10, n. 1, p. 1, doi. 10.1038/s41598-020-60259-0
    By:
    • Shinagawa, Jun;
    • Moteki, Hideaki;
    • Nishio, Shin-ya;
    • Ohyama, Kenji;
    • Otsuki, Koshi;
    • Iwasaki, Satoshi;
    • Masuda, Shin;
    • Oshikawa, Chie;
    • Ohta, Yumi;
    • Arai, Yasuhiro;
    • Takahashi, Masahiro;
    • Sakuma, Naoko;
    • Abe, Satoko;
    • Sakurai, Yuika;
    • Sakaguchi, Hirofumi;
    • Ishino, Takashi;
    • Uehara, Natsumi;
    • Usami, Shin-ichi
    Publication type:
    Article
    48
    49
    50